Key Points
- Hinge Health Chairman Gabriel Mecklenburg sold 150,000 shares at an average price of $93.22, generating approximately $13.98 million. The Rule 10b5-1 transaction cut his ownership by 50% to 150,000 shares.
- Hinge Health reported quarterly earnings of $0.59 per share, beating estimates of $0.28, while revenue reached $212.82 million—up 53% year over year.
- Despite the insider sale, analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $101.93, compared with the stock’s reported opening price of $92.61.
Hinge Health Inc. (NYSE:HNGE - Get Free Report) Chairman Gabriel Mecklenburg sold 150,000 shares of the stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $93.22, for a total transaction of $13,983,000.00. Following the sale, the chairman owned 150,000 shares in the company, valued at $13,983,000. The trade was a 50.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Gabriel M.I. Mecklenburg also recently made the following trade(s):
- On Friday, September 11th, Gabriel Mecklenburg sold 250,000 shares of Hinge Health stock. The shares were sold at an average price of $88.97, for a total transaction of $22,242,500.00.
- On Wednesday, July 1st, Gabriel Mecklenburg sold 83,334 shares of Hinge Health stock. The shares were sold at an average price of $85.05, for a total transaction of $7,087,556.70.
Hinge Health Price Performance
Shares of HNGE opened at $92.61 on Wednesday. Hinge Health Inc. has a one year low of $30.08 and a one year high of $95.57. The company has a market cap of $7.47 billion, a P/E ratio of 72.35 and a beta of 1.38. The firm has a 50 day simple moving average of $86.33 and a two-hundred day simple moving average of $64.89.
Hinge Health (NYSE:HNGE - Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.31. The firm had revenue of $212.82 million during the quarter. Hinge Health had a return on equity of 51.60% and a net margin of 15.15%.The firm's revenue for the quarter was up 53.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.59 earnings per share. On average, analysts expect that Hinge Health Inc. will post 1.25 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
HNGE has been the topic of several research analyst reports. KeyCorp raised their price objective on Hinge Health from $90.00 to $125.00 and gave the company an "overweight" rating in a research note on Monday, July 13th. Evercore reissued an "outperform" rating and set a $105.00 target price on shares of Hinge Health in a research note on Wednesday, August 5th. Zacks Research cut shares of Hinge Health from a "strong-buy" rating to a "hold" rating in a report on Tuesday, August 11th. Piper Sandler reissued an "overweight" rating on shares of Hinge Health in a report on Wednesday, June 10th. Finally, Royal Bank Of Canada raised their price target on shares of Hinge Health from $75.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $101.93.
Get Our Latest Analysis on HNGE
Institutional Investors Weigh In On Hinge Health
Several hedge funds have recently modified their holdings of HNGE. BIT Capital GmbH grew its position in Hinge Health by 79.3% during the 4th quarter. BIT Capital GmbH now owns 3,316,101 shares of the company's stock worth $154,033,000 after acquiring an additional 1,466,577 shares during the last quarter. 11.2 Capital Management LLC bought a new position in Hinge Health in the second quarter valued at about $204,566,531. Wellington Management Group LLP boosted its stake in shares of Hinge Health by 169.7% during the second quarter. Wellington Management Group LLP now owns 1,205,584 shares of the company's stock valued at $100,063,000 after purchasing an additional 758,594 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its stake in shares of Hinge Health by 225.7% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,163,187 shares of the company's stock valued at $44,852,000 after purchasing an additional 806,007 shares in the last quarter. Finally, Alkeon Capital Management LLC grew its holdings in shares of Hinge Health by 110.4% during the fourth quarter. Alkeon Capital Management LLC now owns 791,104 shares of the company's stock worth $36,747,000 after purchasing an additional 415,093 shares during the last quarter.
Hinge Health Company Profile
(
Get Free Report)
Hinge Health, Inc is a digital health company focused on musculoskeletal care. The company provides virtual programs designed to help people manage and improve conditions affecting the back, joints and other areas of the musculoskeletal system, with the goal of supporting conservative care and reducing the need for more invasive treatment.
Its platform combines personalized exercise therapy, digital tools, clinical guidance and behavioral support. Depending on the program, members may use the Hinge Health mobile application, wearable motion sensors and remote care from physical therapists, health coaches and other clinicians.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
